Compare WYETH LTD with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ABBOTT INDIA - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD ABBOTT INDIA WYETH LTD/
ABBOTT INDIA
 
P/E (TTM) x 27.7 52.6 52.7% View Chart
P/BV x 5.3 12.7 42.1% View Chart
Dividend Yield % 1.3 0.5 235.2%  

Financials

 WYETH LTD   ABBOTT INDIA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ABBOTT INDIA
Mar-19
WYETH LTD/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,0448,834 11.8%   
Low Rs8185,458 15.0%   
Sales per share (Unadj.) Rs298.61,731.1 17.2%  
Earnings per share (Unadj.) Rs57.2211.9 27.0%  
Cash flow per share (Unadj.) Rs58.4219.9 26.6%  
Dividends per share (Unadj.) Rs17.0065.00 26.2%  
Dividend yield (eoy) %1.80.9 200.7%  
Book value per share (Unadj.) Rs249.5945.2 26.4%  
Shares outstanding (eoy) m22.7221.25 106.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.1 75.6%   
Avg P/E ratio x16.333.7 48.2%  
P/CF ratio (eoy) x15.932.5 49.1%  
Price / Book Value ratio x3.77.6 49.4%  
Dividend payout %29.730.7 96.8%   
Avg Mkt Cap Rs m21,157151,848 13.9%   
No. of employees `0000.53.5 14.1%   
Total wages/salary Rs m4004,356 9.2%   
Avg. sales/employee Rs Th13,787.410,555.5 130.6%   
Avg. wages/employee Rs Th813.01,249.9 65.0%   
Avg. net profit/employee Rs Th2,643.31,292.2 204.6%   
INCOME DATA
Net Sales Rs m6,78336,786 18.4%  
Other income Rs m3531,133 31.1%   
Total revenues Rs m7,13637,919 18.8%   
Gross profit Rs m1,6176,047 26.7%  
Depreciation Rs m27169 15.7%   
Interest Rs m623 24.4%   
Profit before tax Rs m1,9386,989 27.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6322,485 25.4%   
Profit after tax Rs m1,3014,503 28.9%  
Gross profit margin %23.816.4 145.0%  
Effective tax rate %32.635.6 91.7%   
Net profit margin %19.212.2 156.6%  
BALANCE SHEET DATA
Current assets Rs m6,98427,610 25.3%   
Current liabilities Rs m2,0568,569 24.0%   
Net working cap to sales %72.651.8 140.4%  
Current ratio x3.43.2 105.4%  
Inventory Days Days9960 164.9%  
Debtors Days Days2427 87.4%  
Net fixed assets Rs m2441,057 23.1%   
Share capital Rs m227213 106.9%   
"Free" reserves Rs m5,44119,873 27.4%   
Net worth Rs m5,66820,086 28.2%   
Long term debt Rs m250-   
Total assets Rs m7,90129,409 26.9%  
Interest coverage x353.3311.6 113.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 68.6%   
Return on assets %16.515.4 107.4%  
Return on equity %22.922.4 102.3%  
Return on capital %34.034.9 97.5%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m15369 4.1%   
Fx outflow Rs m2,6774,918 54.4%   
Net fx Rs m-2,662-4,549 58.5%   
CASH FLOW
From Operations Rs m9234,991 18.5%  
From Investments Rs m317-2,570 -12.3%  
From Financial Activity Rs m-481-1,428 33.7%  
Net Cashflow Rs m759993 76.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 75.0 68.1%  
Indian inst/Mut Fund % 11.3 7.9 143.0%  
FIIs % 7.2 0.1 7,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 17.1 177.8%  
Shareholders   21,978 18,270 120.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   PROCTER & GAMBLE HEALTH  IPCA LABS  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Higher; IT and Banking Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended higher. Benchmark Indices were highly volatile swinging between positive and negative territory.

Related Views on News

IPCA LABS at All Time High; BSE HEALTHCARE Index Down 0.1% (Market Updates)

Nov 14, 2019 | Updated on Nov 14, 2019

IPCA LABS share price has hit an all time high at Rs 1,146 (up 4.7%). The BSE HEALTHCARE Index is down by 0.1%. Among the top gainers in the BSE HEALTHCARE Index today are IPCA LABS (up 4.7%) and ABBOTT INDIA (up 1.8%). The top losers include NATCO PHARMA (down 0.1%) and PFIZER (down 0.1%).

IPCA LABS at All Time High; BSE HEALTHCARE Index Up 0.1% (Market Updates)

Nov 14, 2019 | Updated on Nov 14, 2019

IPCA LABS share price has hit an all time high at Rs 1,119 (up 2.7%). The BSE HEALTHCARE Index is up by 0.1%. Among the top gainers in the BSE HEALTHCARE Index today are IPCA LABS (up 2.7%) and ABBOTT INDIA (up 3.0%). The top losers include ERIS LIFESCIENCES LIMITED and DR. REDDYS LAB (down 0.1%).

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS